Vanessa L. Ford

Array ( [id] => 7463801 [patent_doc_number] => 20040101531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Immunogenic compositions and vaccines comprising carrier bacteria that secrete antigens' [patent_app_type] => new [patent_app_number] => 10/414532 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 20311 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101531.pdf [firstpage_image] =>[orig_patent_app_number] => 10414532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7182883 [patent_doc_number] => 20040203006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Novel beta-tubulin protein of Candida glabrata and methods for its use' [patent_app_type] => new [patent_app_number] => 10/412439 [patent_app_country] => US [patent_app_date] => 2003-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8796 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20040203006.pdf [firstpage_image] =>[orig_patent_app_number] => 10412439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7385914 [patent_doc_number] => 20040082530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Nucleic acid immunization' [patent_app_type] => new [patent_app_number] => 10/411205 [patent_app_country] => US [patent_app_date] => 2003-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14721 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082530.pdf [firstpage_image] =>[orig_patent_app_number] => 10411205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6729646 [patent_doc_number] => 20030185836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Cryptosporidium sporozoite antigens' [patent_app_type] => new [patent_app_number] => 10/148687 [patent_app_country] => US [patent_app_date] => 2003-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12370 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20030185836.pdf [firstpage_image] =>[orig_patent_app_number] => 10148687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874460 [patent_doc_number] => 20030194757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Peptides for detection of antibody to A. phagocytophilia' [patent_app_type] => new [patent_app_number] => 10/404626 [patent_app_country] => US [patent_app_date] => 2003-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6137 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20030194757.pdf [firstpage_image] =>[orig_patent_app_number] => 10404626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7316385 [patent_doc_number] => 20040034883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Fungl elicitor and process for its preparation' [patent_app_type] => new [patent_app_number] => 10/380878 [patent_app_country] => US [patent_app_date] => 2003-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6944 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20040034883.pdf [firstpage_image] =>[orig_patent_app_number] => 10380878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7364337 [patent_doc_number] => 20040091949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Method of screening drug acting on cell wall' [patent_app_type] => new [patent_app_number] => 10/258579 [patent_app_country] => US [patent_app_date] => 2003-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7598 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091949.pdf [firstpage_image] =>[orig_patent_app_number] => 10258579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7429995 [patent_doc_number] => 20040001867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Vectors for molecule delivery to CD11b expressing cells' [patent_app_type] => new [patent_app_number] => 10/387486 [patent_app_country] => US [patent_app_date] => 2003-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 19514 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20040001867.pdf [firstpage_image] =>[orig_patent_app_number] => 10387486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701139 [patent_doc_number] => 20030224019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Methods of treating nerve entrapment syndromes' [patent_app_type] => new [patent_app_number] => 10/378042 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2841 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224019.pdf [firstpage_image] =>[orig_patent_app_number] => 10378042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6739764 [patent_doc_number] => 20030157133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Lipoteichoic acid immunogenic compositions and methods of making and using thereof' [patent_app_type] => new [patent_app_number] => 10/370596 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7123 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157133.pdf [firstpage_image] =>[orig_patent_app_number] => 10370596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7440194 [patent_doc_number] => 20040009178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Immunotherapeutics for biodefense' [patent_app_type] => new [patent_app_number] => 10/364743 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13933 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009178.pdf [firstpage_image] =>[orig_patent_app_number] => 10364743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787221 [patent_doc_number] => 20030138460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Methods of treating animals with botulinum toxin pharmaceutical compositions' [patent_app_type] => new [patent_app_number] => 10/360098 [patent_app_country] => US [patent_app_date] => 2003-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19402 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138460.pdf [firstpage_image] =>[orig_patent_app_number] => 10360098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 42037 [patent_doc_number] => 07780967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-24 [patent_title] => 'Reduced toxicity Clostridial toxin pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 10/359828 [patent_app_country] => US [patent_app_date] => 2003-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20407 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/780/07780967.pdf [firstpage_image] =>[orig_patent_app_number] => 10359828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701124 [patent_doc_number] => 20030224004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Chlamydia antigens and corresponding DNA fragments and uses thereof' [patent_app_type] => new [patent_app_number] => 10/359289 [patent_app_country] => US [patent_app_date] => 2003-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16377 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224004.pdf [firstpage_image] =>[orig_patent_app_number] => 10359289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796423 [patent_doc_number] => 20030175297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Cancer vaccines' [patent_app_type] => new [patent_app_number] => 10/346940 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6385 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175297.pdf [firstpage_image] =>[orig_patent_app_number] => 10346940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711509 [patent_doc_number] => 20030171258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Particle based vaccine composition' [patent_app_type] => new [patent_app_number] => 10/335906 [patent_app_country] => US [patent_app_date] => 2003-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3229 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171258.pdf [firstpage_image] =>[orig_patent_app_number] => 10335906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797508 [patent_doc_number] => 20030176382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Treatment of hookworm infection' [patent_app_type] => new [patent_app_number] => 10/220083 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2431 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176382.pdf [firstpage_image] =>[orig_patent_app_number] => 10220083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6760778 [patent_doc_number] => 20030124139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Compositions and methods for stabilizing biological molecules upon lyophilization' [patent_app_type] => new [patent_app_number] => 10/148559 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6481 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124139.pdf [firstpage_image] =>[orig_patent_app_number] => 10148559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7164855 [patent_doc_number] => 20040076638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Methods for preparing bacillus anthracis protective antigen for use in vaccines' [patent_app_type] => new [patent_app_number] => 10/290712 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10791 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20040076638.pdf [firstpage_image] =>[orig_patent_app_number] => 10290712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199642 [patent_doc_number] => 20040086532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Botulinum toxin formulations for oral administration' [patent_app_type] => new [patent_app_number] => 10/288906 [patent_app_country] => US [patent_app_date] => 2002-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17761 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086532.pdf [firstpage_image] =>[orig_patent_app_number] => 10288906 [rel_patent_id] =>[rel_patent_doc_number] =>)